L L Montgomery

Summary

Affiliation: Memorial Sloan-Kettering Cancer Center
Country: USA

Publications

  1. ncbi Issues of regret in women with contralateral prophylactic mastectomies
    L L Montgomery
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Ann Surg Oncol 6:546-52. 1999
  2. ncbi Isosulfan blue dye reactions during sentinel lymph node mapping for breast cancer
    Leslie L Montgomery
    Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Anesth Analg 95:385-8, table of contents. 2002
  3. ncbi Intradermal isotope injection: a highly accurate method of lymphatic mapping in breast carcinoma
    S K Boolbol
    Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA
    Ann Surg Oncol 8:20-4. 2001
  4. ncbi Lymphovascular invasion enhances the prediction of non-sentinel node metastases in breast cancer patients with positive sentinel nodes
    M R Weiser
    Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA
    Ann Surg Oncol 8:145-9. 2001
  5. ncbi Patient reluctance toward tamoxifen use for breast cancer primary prevention
    E R Port
    Breast Service, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA
    Ann Surg Oncol 8:580-5. 2001
  6. ncbi Intradermal isotope injection is superior to intramammary in sentinel node biopsy for breast cancer
    R C Martin
    Breast Service, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
    Surgery 130:432-8. 2001
  7. ncbi A prospective analysis of the effect of blue-dye volume on sentinel lymph node mapping success and incidence of allergic reaction in patients with breast cancer
    Tari A King
    Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Ann Surg Oncol 11:535-41. 2004
  8. ncbi Results of MRI screening for breast cancer in high-risk patients with LCIS and atypical hyperplasia
    Elisa Rush Port
    Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Ann Surg Oncol 14:1051-7. 2007
  9. ncbi Reoperative sentinel lymph node biopsy: a new option for patients with primary or locally recurrent breast carcinoma
    Elisa Rush Port
    Breast Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
    J Am Coll Surg 195:167-72. 2002
  10. ncbi The accuracy of sentinel lymph node biopsy in multicentric and multifocal invasive breast cancers
    Eleni Tousimis
    Breast Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
    J Am Coll Surg 197:529-35. 2003

Collaborators

Detail Information

Publications12

  1. ncbi Issues of regret in women with contralateral prophylactic mastectomies
    L L Montgomery
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Ann Surg Oncol 6:546-52. 1999
    ..We have developed a National Prophylactic Mastectomy Registry comprised of a volunteer population of 817 women from 43 states who have undergone prophylactic (unilateral or bilateral) mastectomy...
  2. ncbi Isosulfan blue dye reactions during sentinel lymph node mapping for breast cancer
    Leslie L Montgomery
    Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Anesth Analg 95:385-8, table of contents. 2002
    ..Bronchospasm and respiratory compromise are unusual, and most patients can be treated with short-term pressor support. Patients with a sulfa allergy do not display a cross-sensitivity to isosulfan blue dye...
  3. ncbi Intradermal isotope injection: a highly accurate method of lymphatic mapping in breast carcinoma
    S K Boolbol
    Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA
    Ann Surg Oncol 8:20-4. 2001
    ..Further investigation is warranted before this technique is adopted for use in larger breast cancers. Intraoperative examination and biopsy of any suspicious nonsentinel nodes are critical...
  4. ncbi Lymphovascular invasion enhances the prediction of non-sentinel node metastases in breast cancer patients with positive sentinel nodes
    M R Weiser
    Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA
    Ann Surg Oncol 8:145-9. 2001
    ..CONCLUSION: Patients with small breast cancers, no LVI, and SLN micrometastases have a low risk of non-SLN metastases, and may not require completion ALND...
  5. ncbi Patient reluctance toward tamoxifen use for breast cancer primary prevention
    E R Port
    Breast Service, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA
    Ann Surg Oncol 8:580-5. 2001
    ..CONCLUSIONS: In this study, the vast majority of patients at increased risk for breast cancer perceived that the risks of taking tamoxifen outweighed the benefits and declined to take it...
  6. ncbi Intradermal isotope injection is superior to intramammary in sentinel node biopsy for breast cancer
    R C Martin
    Breast Service, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
    Surgery 130:432-8. 2001
    ..The dermal and parenchymal lymphatics of the breast drain to the same axillary SLN in most breast cancer patients, and ID isotope injection is the procedure of choice in this setting...
  7. ncbi A prospective analysis of the effect of blue-dye volume on sentinel lymph node mapping success and incidence of allergic reaction in patients with breast cancer
    Tari A King
    Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Ann Surg Oncol 11:535-41. 2004
    ..This study examined whether the volume of isosulfan blue dye used in sentinel lymph node (SLN) mapping in breast cancer is related to the SLN identification rate or to the incidence of allergic reactions...
  8. ncbi Results of MRI screening for breast cancer in high-risk patients with LCIS and atypical hyperplasia
    Elisa Rush Port
    Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Ann Surg Oncol 14:1051-7. 2007
    ..More data are needed to define the role of MRI screening for specific high-risk groups. We describe our experience with MRI screening in patients with atypical hyperplasia (AH) and lobular carcinoma in situ (LCIS)...
  9. ncbi Reoperative sentinel lymph node biopsy: a new option for patients with primary or locally recurrent breast carcinoma
    Elisa Rush Port
    Breast Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
    J Am Coll Surg 195:167-72. 2002
    ..Further study is required to better define the subset of patients in whom reoperative SLN biopsy can replace ALND...
  10. ncbi The accuracy of sentinel lymph node biopsy in multicentric and multifocal invasive breast cancers
    Eleni Tousimis
    Breast Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
    J Am Coll Surg 197:529-35. 2003
    ..Our retrospective data suggest SLNB may be used as a reliable alternative to conventional ALND in selected patients with MC or MF disease. Further studies in this patient population are warranted...
  11. ncbi Unilateral postoperative chest wall radiotherapy in bilateral tissue expander/implant reconstruction patients: a prospective outcomes analysis
    Colleen M McCarthy
    Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
    Plast Reconstr Surg 116:1642-7. 2005
    ..These data support the conclusion that immediate, bilateral breast reconstruction using tissue expansion and implants is an acceptable option for the subset of patients who may undergo unilateral, postexchange radiotherapy...
  12. ncbi Sensory morbidity after sentinel lymph node biopsy and axillary dissection: a prospective study of 233 women
    Larissa K F Temple
    Department of Surgery, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    Ann Surg Oncol 9:654-62. 2002
    ..Sensory morbidity improves in the first 3 months after surgery, but patients continue to report sensory morbidity at 1 year. Longitudinal follow-up is required to further assess lymphedema...